ICU Medical Net Worth
ICU Medical Net Worth Breakdown | ICUI |
ICU Medical Net Worth Analysis
ICU Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ICU Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ICU Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ICU Medical's net worth analysis. One common approach is to calculate ICU Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ICU Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ICU Medical's net worth. This approach calculates the present value of ICU Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ICU Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ICU Medical's net worth. This involves comparing ICU Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ICU Medical's net worth relative to its peers.
To determine if ICU Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ICU Medical's net worth research are outlined below:
| ICU Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 2.26 B. Net Loss for the year was (29.66 M) with profit before overhead, payroll, taxes, and interest of 697.76 M. | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: ICU Medical, Inc. Given Consensus Recommendation of Moderate Buy by Analysts |
ICU Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ICU Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ICU Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know ICU Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ICU Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ICU Medical backward and forwards among themselves. ICU Medical's institutional investor refers to the entity that pools money to purchase ICU Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 547 K | Millennium Management Llc | 2024-09-30 | 538.1 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 457 K | Neuberger Berman Group Llc | 2024-09-30 | 444.9 K | Silvercrest Asset Management Group Llc | 2024-09-30 | 380.6 K | Northern Trust Corp | 2024-09-30 | 362.2 K | Segall Bryant & Hamill | 2024-09-30 | 333.4 K | Btim Corp | 2024-09-30 | 326.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 301.1 K | Blackrock Inc | 2024-06-30 | 3.3 M | Vanguard Group Inc | 2024-09-30 | 2.7 M |
Follow ICU Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.84 B.Project ICU Medical's profitablity
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.When accessing ICU Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ICU Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ICU Medical's profitability and make more informed investment decisions.
Evaluate ICU Medical's management efficiency
ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities.ICU Medical benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Enterprise Value Revenue 2.2169 | Revenue 2.3 B | Quarterly Revenue Growth 0.065 | Revenue Per Share 96.302 | Return On Equity (0.05) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ICU Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on ICU Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ICU Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ICU Medical Corporate Filings
F4 | 6th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 2nd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 18th of July 2024 An amendment to the original Schedule 13D filing | ViewVerify |
ICU Medical Earnings per Share Projection vs Actual
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (4.57) | Revenue Per Share 96.302 | Quarterly Revenue Growth 0.065 | Return On Assets 0.0066 |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.